Esuprone

Esuprone
	IUPAC name 3,4-Dimethyl-2-oxo-2H-chromen-7-yl ethanesulfonate
Identifiers
CAS number	91406-11-0
PubChem	65827
ChemSpider	59239
UNII	K7EB9E48ZE
ChEMBL	CHEMBL18504
Jmol-3D images	Image 1
	SMILES O=S(=O)(Oc2ccc\1c(OC(=O)/C(=C/1C)C)c2)CC ;
	InChI InChI=1S/C13H14O5S/c1-4-19(15,16)18-10-5-6-11-8(2)9(3)13(14)17-12(11)7-10/h5-7H,4H2,1-3H3 ; Key: CHDGAVDQRSPBTA-UHFFFAOYSA-N InChI=1/C13H14O5S/c1-4-19(15,16)18-10-5-6-11-8(2)9(3)13(14)17-12(11)7-10/h5-7H,4H2,1-3H3; Key: CHDGAVDQRSPBTA-UHFFFAOYAR ;
Properties
Molecular formula	C13H14O5S
Molar mass	282.31 g mol−1
	(verify) (what is: /?); Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa)
	Infobox references

From Wikipedia, the free encyclopedia

Jump to: navigation, search

Esuprone is an experimental drug candidate being investigated as an antidepressant.^[2] It acts as an monoamine oxidase A (MAO-A) inhibitor.^[3]

[edit] References

^ Ganellin, C. R (1996). Dictionary of pharmacological agents. CRC Press. pp. 1056. ISBN 978-0412466304.
^ Vértes, Attila (2003). Handbook of nuclear chemistry. Springer. pp. 155. ISBN 978-1402013164.
^ Bergström, M; Westerberg, G; Németh, G; Traut, M; Gross, G; Greger, G; Müller-Peltzer, H; Safer, A et al (1997). "MAO-A inhibition in brain after dosing with esuprone, moclobemide and placebo in healthy volunteers: In vivo studies with positron emission tomography". European journal of clinical pharmacology 52 (2): 121–8. PMID 9174681.